{"name":"Amyloid Solution Inc","slug":"amyloid-solution-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AS-S603","genericName":"AS-S603","slug":"as-s603","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AS-S603","genericName":"AS-S603","slug":"as-s603","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE9CajJhTkdSLTV6eTg2NDZKdl93TzgyRE5UalVVOHJaU0lyTFRzdlNtS3NTY2xVTnI2UUtpU011ZFNnMV9JQ01naUhCUzNIeGpKeWE5UzBCT1JXWWQ3QWNsaXp0WdIBY0FVX3lxTE9CajJhTkdSLTV6eTg2NDZKdl93TzgyRE5UalVVOHJaU0lyTFRzdlNtS3NTY2xVTnI2UUtpU011ZFNnMV9JQ01naUhCUzNIeGpKeWE5UzBCT1JXWWQ3QWNsaXp0WQ?oc=5","date":"2026-03-03","type":"pipeline","source":"Bitget","summary":"Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026 - Bitget","headline":"Acumen Pharmaceuticals to Showcase Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Park","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNUTc4dEs0elh0dWFYNEZOaHBCSTY3enc5MHlNRTlvdFpWaWIyWkM5eVVkTUhEX0NnZ3RrUkRZTkpnejg0WGJpY2RYZU05ZTRLWldkWE9pN0IxU19TTjQtY2VnakRka2xZQ2V4dWR2UTVRdWI1a1JzN3VzMGVWVGVNWWJlSzRJZDVkZFFsT01JMUFhU21wbDNsaGpGX0k2NDZOR2Rn?oc=5","date":"2025-12-16","type":"deal","source":"BioWorld News","summary":"ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug - BioWorld News","headline":"ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE81VTFDZkVsMXBOZjJfRENyT1NTNnFQVTBELS1malBnNGFwVTVGSGRhaGd3d0FvLU9nRFhNS3piaURZdVFYRWs1ck95ei1yRUo2UXFuZmc0NXVqZGdZMm1WeU1QWG0xdjRJaHhEODhn0gFyQVVfeXFMTnNCdEg4TmRvRkdEYXd0aHhKZVpwTWcwU3VZbXJWWm1hR2dVMm9wa2lZTmhRTThDZEd5TDNQYnRjcWFyZ1RCRjhkWUl5UnVxRlFEak9LRzVSVG55ejItdnFSRlpZVENzaHZuLWdnVUNrd2RB?oc=5","date":"2025-09-25","type":"deal","source":"koreabiomed.com","summary":"Illimis and Lilly partner on ARIA-free Alzheimer’s therapy - koreabiomed.com","headline":"Illimis and Lilly partner on ARIA-free Alzheimer’s therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxOMU1Sa1RwVmNEdzJ4YU5vejNmR0h3Sk9DNWwyUkZZRXlPNGRLaVo1TDhsdENCQ3Z2UkpaUnZIc1hrV2h5YmhtR1AxMS11bVVSbEN6ZTlIZE9CR2h2bEMzM3J2R0Uxb1h3QnlmM2c1VGpjOXJGdUE4UEc4LUs0bVVMblJvWjZiNlc5UWZiRUc4WWs5N3pMaWNpZ2xCZFpTZUt3alUzZzRqREsteEdyQ1NEZ2w2NzliNGI2X3lDcHotYmlmaU1HdVRUaThHOTVvdVYtWk0wWXhETmhCaXpWUWRVYUk4TEZvWGlQdlFtUDE0bXo0R1VpQXlzbmxhTlQ0bUgzRDBCLWdiSnNsUQ?oc=5","date":"2025-09-10","type":"deal","source":"Business Wire","summary":"GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions - Business Wire","headline":"GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solution","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxQT0pEZkxiU3RVdGtubnRuM0RVNzZxZTRxaDFIOFVUTGFLbHNSUUF4M2xCQk1vQTdaSmFlY2VwdU81ckdGcmtxUTZhel9NV0IySHV2TFNha1N4RG13eGRjQl9KYllFbWdYWW1kZmFWY2ZEVXpCWm5qQktRMi0wdGd6NFhKM1NZbU95UjEwa2ozOXd6dkFmM1JHT0NiVjFhdWVmRk5tYks4NnJORGh6RklKWm03bjY0eDN6QTNldU85NkNwMzBoYjd4UzFVX0poOHQ2cUVsLVgyOEJZMWc1MzFGWktIZGxmQ2ptUEFFNlV1ZkZ5NFNsVTVmZDFoN2h0TWNDR0gzS2lJeXZOOExoZ3o3cDhRaC1LZVpMU1FhRm00YlRQaS11akpVWG5RTDVtakVFTE43RHVtTlA?oc=5","date":"2025-07-15","type":"deal","source":"Business Wire","summary":"JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform - Business Wire","headline":"JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer’s Disease, Enable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNSmlyMndNNTZZSDB5QVhSM09aQlRvMXNLZHFEV3JMcm8wbjhYLWhvQUZ1dldmcVpKY3FRb2tnM3Z0czdDNjJqdVQtMGV4akFkNmlINFl0X0dkcThtbEJmN3liVUdxaXZlNm52Q0VlYVFETGk5Sl9TaUZJNHJ1YXBqdjNQbjNyV1hmMWlwSXZac1QzMUk5eWVyQkdSQzgxbFRTT1kxYlZFcnkycFltblZHSHJDNjE4NFpQLURsTjVnUjl1VG82RnpHYnE0ZklmTTRHSUpTYjRhUThzY2tzeWh1ODM0QUdORzQwTnZPcGExa05sLTJfOFZhcDRVZHZzSENmbXRnc1BhVjdFREVieXM5czdB?oc=5","date":"2025-06-09","type":"pipeline","source":"Business Wire","summary":"(vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy - Business Wire","headline":"(vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOcW9mN0hRZjBLZlY3NWs5ZjBRb1BUbHR4ZFozWS1BaVRpS1hyOFZFZ2dKNUk3WVg5bmFOc01oaDN5ZGhzYUFZODY3Wnh2VWVwRXRIWkV6WmNWREpCdW1iYkxyaG5QOXg5X3RWcjdWRThGNHI0bVplaTVTYVBKRm5DcUxjYW44RkhWY2pVN0hLbzROVDZ2U1pZTjVGNHVFMDYtX29VZExLcThQQjZJeUlmRXFJdml5VFVEM2RXRW05bHhGU2VTanEwX19ERVR6VmQ4bkQtaUNqZVA?oc=5","date":"2025-05-14","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Sweet Solution: Sugar-Coated Nanotherapy Halts Alzheimer’s Disease by Trapping Toxic Proteins - Genetic Engineering and Biotechnology News","headline":"Sweet Solution: Sugar-Coated Nanotherapy Halts Alzheimer’s Disease by Trapping Toxic Proteins","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-20","type":"regulatory","source":"Business Wire","summary":"Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis wi","headline":"Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hos","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPVk9MT2Zkek8yeEdHVFZrRzU2cTlJWkFUM0UzWTdqQURwR0dxeVVHSXlCUkxRUWZqb2hlYWdxMS1EN2ozMHI4TFk5dExua3ZyNGNQaUVUQVFfdXY2N0pramNxdDZyN1Jmd211eFFvWmowUmNtVHlDTF8ySmNPZ3hzbjlHUFFEVTJwMEpqRVozaDRkdHdOT1RqcWdDc2JqemJJM0NrZDNNcDE0OEdzUmYxWHJJcURnOUxEbjJwQ3Q2MjI?oc=5","date":"2023-11-21","type":"trial","source":"dicardiology.com","summary":"BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) - dicardiology.com","headline":"BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patient","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1kRzNzSGJKXy14ZTlTNTY5QnU4d1ZxUmI0Q2xjdUR5Z19TWjVXYUZIbWEzYk9qWjZnakJyWGpwTXdGUWN4a1BfYzhQZkhhTjB0elJWYmhKNnhVLVZLWEpyWENDRWJPU0FsUWlZcjJ3d0l5a3prX2ZuTXFUQ3FJWXM?oc=5","date":"2023-05-24","type":"pipeline","source":"KED Global","summary":"Neurophet strives to be first mover in fight against Alzheimer’s - KED Global","headline":"Neurophet strives to be first mover in fight against Alzheimer’s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQbHg2X0gwLWNEQVA1YjJTazQwdEUweEdRalV1SEVFdFJpUE03dUMyMmVuWXB0ZlJWZDEyY2s2cVlPR1NUUXBUamJsajJrYzVEckU2RGhuVmFHa2ltVlEwR0lWSzhUNVp1U3hHWmJKaDV6aVUwLWpiZ3dYTlEzTlRGelg1MDJERUE2d1Br?oc=5","date":"2022-03-18","type":"pipeline","source":"Pharma Voice","summary":"Attralus’ medical officer believes systemic amyloidosis could be ‘solvable’ - Pharma Voice","headline":"Attralus’ medical officer believes systemic amyloidosis could be ‘solvable’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE5Ta0RXSU9kcVZGMVhqV1VCUVpja0ljTlB5akdpMWlGVm5qa2ZDVHktYndWaXk1S29aYXpEM0FreVMzLXhpZHBGR2lxZ1hsRzF2Z1ZQaTFEbw?oc=5","date":"2020-04-16","type":"pipeline","source":"바이오스펙테이터","summary":"Amyloid Solution raises $14.8M Series B...Yuhan participates as strategic investor - 바이오스펙테이터","headline":"Amyloid Solution raises $14.8M Series B...Yuhan participates as strategic investor - 바이오스펙테이터","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}